Burrows Francis (CIK 2051119) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-27). Recent activity: Sell KURA (1,311 shares), Buy KURA (35,000 shares), Sell KURA (23,726 shares), Sell KURA (846 shares), Sell KURA (1,320 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-27 | Kura Oncology, Inc. (KURA) | Chief Scientific Officer | Sell | 1,311 | $11,091 |
| 2025-12-19 | Kura Oncology, Inc. (KURA) | Chief Scientific Officer | Buy | 35,000 | $168,000 |
| 2025-12-19 | Kura Oncology, Inc. (KURA) | Chief Scientific Officer | Sell | 23,726 | $232,040 |
| 2025-01-28 | Kura Oncology, Inc. (KURA) | Chief Scientific Officer | Sell | 846 | $6,658 |
| 2025-01-28 | Kura Oncology, Inc. (KURA) | Chief Scientific Officer | Sell | 1,320 | $10,388 |
Source: SEC Form 4 filings · as of 2026-01-27